These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15046532

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nonstimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T, Biederman J, Wilens T.
    Psychiatr Clin North Am; 2004 Jun; 27(2):373-83. PubMed ID: 15064003
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV.
    Drug Alcohol Depend; 2006 Feb 01; 81(2):137-48. PubMed ID: 16102908
    [Abstract] [Full Text] [Related]

  • 6. Integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
    Horst RO, Hendren RL.
    Essent Psychopharmacol; 2005 Feb 01; 6(5):250-61. PubMed ID: 16222910
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES.
    J Fam Pract; 1999 Jan 01; 48(1):15-20. PubMed ID: 9934377
    [Abstract] [Full Text] [Related]

  • 10. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J.
    J Clin Psychiatry; 1998 Jan 01; 59 Suppl 7():4-16. PubMed ID: 9680048
    [Abstract] [Full Text] [Related]

  • 11. Impact of ADHD and its treatment on substance abuse in adults.
    Wilens TE.
    J Clin Psychiatry; 2004 Jan 01; 65 Suppl 3():38-45. PubMed ID: 15046534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May 01; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 14. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult.
    Greydanus DE, Pratt HD, Patel DR.
    Dis Mon; 2007 Feb 01; 53(2):70-131. PubMed ID: 17386306
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, Weiss M, Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.
    Ann Clin Psychiatry; 2012 Feb 01; 24(1):23-37. PubMed ID: 22303520
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel treatments for attention-deficit/hyperactivity disorder in children.
    Spencer TJ, Biederman J, Wilens TE, Faraone SV.
    J Clin Psychiatry; 2002 Feb 01; 63 Suppl 12():16-22. PubMed ID: 12562057
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.